Painful Eruptions in a Patient With Cholangiocarcinoma Treated With Fibroblast Growth Factor Receptor Inhibitor

被引：0
|
作者：
Wylie, Natasha S. [1 ]
Sokumbi, Olayemi [2 ]
Starr, Jason S. [1 ]
机构：
[1] Mayo Clin, Div Hematol & Med Oncol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA
[2] Mayo Clin, Dept Dermatol, Jacksonville, FL 32224 USA
来源：
JAMA ONCOLOGY | 2021年 / 7卷 / 12期
关键词：
D O I：
10.1001/jamaoncol.2021.5578
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1891 / 1892
页数：2
相关论文
共 50 条
  • [41] Fibroblast growth factor receptor 4 promotes progression and correlates Cross Mark to poor prognosis in cholangiocarcinoma
    Xu, Yun-Fei
    Yang, Xiao-Qing
    Lu, Xiao-Fei
    Guo, Sen
    Liu, Yi
    Iqbal, Mohammad
    Ning, Shang-Lei
    Yang, Hui
    Suo, Ning
    Chen, Yu-Xin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 446 (01) : 54 - 60
  • [42] Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations
    Lee, Patrick C.
    Hendifar, Andrew
    Osipov, Arsen
    Cho, May
    Li, Daneng
    Gong, Jun
    CANCERS, 2021, 13 (07)
  • [43] A Case of Fibroblast Growth Factor Receptor Fusion-Positive Intrahepatic Cholangiocarcinoma With Humoral Hypercalcemia of Malignancy
    Chauhan, Aditya
    Likasitwatanakul, Pornlada
    Ahmed, Ammar
    Sibley, Shalamar D.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [44] Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma
    Kabashima, Ayano
    Hirsova, Petra
    Bronk, Steven F.
    Hernandez, Matthew C.
    Truty, Mark J.
    Ilyas, Sumera I.
    Kaufmann, Scott H.
    Gores, Gregory J.
    JOURNAL OF HEPATOLOGY, 2018, 68 (06) : 1228 - 1238
  • [45] Efficacy of TAS-120, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in cholangiocarcinoma patients with FGFR pathway alterations who were previously treated with chemotherapy and other FGFR inhibitors
    Meric-Bernstam, F.
    Arkenau, H.
    Tran, B.
    Bahleda, R.
    Kelley, R.
    Hierro, C.
    Ahn, D.
    Zhu, A.
    Javle, M.
    Winkler, R.
    He, H.
    Huang, J.
    Goyal, L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [46] Structural Characterization of the Interaction of the Fibroblast Growth Factor Receptor with a Small Molecule Allosteric Inhibitor
    Kappert, Franziska
    Sreeramulu, Sridhar
    Jonker, Hendrik R. A.
    Richter, Christian
    Rogov, Vladimir V.
    Proschak, Ewgenij
    Hargittay, Bruno
    Saxena, Krishna
    Schwalbe, Harald
    CHEMISTRY-A EUROPEAN JOURNAL, 2018, 24 (31) : 7861 - 7865
  • [47] Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated Retinopathy
    Francis, Jasmine H.
    Harding, James J.
    Schram, Alison M.
    Canestraro, Julia
    Haggag-Lindgren, Dianna
    Heinemann, Murk
    Kriplani, Anuja
    Jhaveri, Komal
    Voss, Martin H.
    Bajorin, Dean
    Abou-Alfa, Ghassan K.
    Iyer, Gopa
    Drilon, Alexander
    Rosenberg, Jonathan
    Abramson, David H.
    JAMA OPHTHALMOLOGY, 2021, 139 (10) : 1126 - 1130
  • [48] Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological study
    Sasaki, Motoko
    Sato, Yasunori
    Nakanuma, Yasuni
    VIRCHOWS ARCHIV, 2024, 484 (06) : 915 - 923
  • [49] Complete Response to a Fibroblast Growth Factor Receptor Inhibitor in a Patient With Head and Neck Squamous Cell Carcinoma Harboring FGF Amplifications
    Dumbrava, Ecaterina Ileana
    Alfattal, Rash A.
    Miller, Vincent A.
    Tsimberidou, Apostolia Maria
    JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 7
  • [50] Fibroblast growth factor-derived peptides: Functional agonists of the fibroblast growth factor receptor
    Li, Shizhong
    Christensen, Claus
    Kiselyov, Vladislav V.
    Kohler, Lene B.
    Bock, Elisabeth
    Berezin, Vladimir
    JOURNAL OF NEUROCHEMISTRY, 2008, 104 (03) : 667 - 682
12345